NCT05337228View on ClinicalTrials.gov

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301

PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

February 10, 2023

Study Completion Date

February 24, 2023

Conditions
Parenteral Nutrition
Interventions
DRUG

IN-C006 Peri inj.

IN-C006 peri inj. will be injected continuously for 3 days.

DRUG

RPN301

RPN301 will be injected continuously for 3 days.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY